Phio Pharmaceuticals director Plott buys $17,100 in shares
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Health & Medicine
Canucks: Wes Rypien shifts focus to minor hockey mental health
Fifteen years after Rick Rypien's death, his brother says support for NHL players has improved. But youth leagues have a long way to go
'I was so mentally ready': B.C. teenager's 2½-year wait for spinal surgery drags on
Victoria's Dillyn Burrows will have to wait until at least the new year as an October surgery date was pushed back
TIME's Longevity Leaders Are Racing to Add Good Years to Your Life
TIME set out to find some of the most innovative leaders who are starting to show concrete results in helping us to live longer, better.
STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
A Regeneron drug for an ultra-rare disease that causes bone to grow where it shouldn't won U.S. regulatory approval, capping a three-decade effort
Shinya Yamanaka Made Cells Young Again. Can That Reverse Aging?
Twenty years after his Nobel-winning discovery, doctors are using Yamanaka's cell-reprogramming breakthrough to treat real patients—and address aging itself.
Muscle Isn't Vanity. Gabrielle Lyon Says It's Preventive Medicine
Physician and author Dr. Gabrielle Lyon argues doctors have spent fifty years treating longevity as a fat problem, when it's really a muscle problem.